Sign inJoin waitlistJoin the waitlist

MB

Michael Brave

Personal Emergency Response Attendant

Credentials: ·

Research

FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors
Clinical Cancer Research · 2022 · 143 citations
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
Journal of Clinical Oncology · 2024 · 49 citations
A U.S. Food and Drug Administration-pooled Analysis of Frontline Combination Treatment Survival Benefits by Risk Groups in Metastatic Renal Cell Carcinoma
European Urology · 2023 · 21 citations

RP
Richard Pazdur
12 papers
CW
Chana Weinstock
8 papers
DS
Daniel Suzman
8 papers
PK
Paul Kluetz
6 papers
JF
Jaleh Fallah
5 papers
DC
Dow-Chung Chi
2 papers
GM
Gautam Mehta
2 papers
GK
Geoffrey Kim
2 papers
MT
Marc Theoret
2 papers
VB
Vishal Bhatnagar
2 papers
AF
Ann Farrell
1 paper
BH
Brian Heiss
1 paper